BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35150707)

  • 21. Low-dose aspirin can inhibit exosomal release induced by radiotherapy in breast cancer and attenuate its inhibitory effect on NK cell proliferation.
    Wang L; Hu Z; Chen C; Chen T; Yao Z; Li W; Yang Z
    Cancer Med; 2023 Aug; 12(15):16386-16404. PubMed ID: 37392173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted delivery of doxorubicin to HER2 positive tumor models.
    Gomari H; Forouzandeh Moghadam M; Soleimani M; Ghavami M; Khodashenas S
    Int J Nanomedicine; 2019; 14():5679-5690. PubMed ID: 31413568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells.
    Hannafon BN; Gin AL; Xu YF; Bruns M; Calloway CL; Ding WQ
    Cell Commun Signal; 2019 Feb; 17(1):13. PubMed ID: 30782165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer.
    Pakravan N; Abbasi A; Hassan ZM
    Oxid Med Cell Longev; 2021; 2021():5529484. PubMed ID: 34194604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
    Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
    Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The transmission and toxicity of polymer-bound doxorubicin-containing exosomes derived from human adenocarcinoma cells.
    Gunár K; Kotrchová L; Filipová M; Krunclová T; Dydowiczová A; Pola R; Randárová E; Etrych T; Janoušková O
    Nanomedicine (Lond); 2022 Aug; 17(19):1307-1322. PubMed ID: 36255034
    [No Abstract]   [Full Text] [Related]  

  • 28. Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro.
    Rashidi M; Mahmoudian E; Mirzaei S; Mazloomi SN; Bazi A; Azadeh H; Mozaffari M
    Chem Biol Interact; 2022 Sep; 365():110087. PubMed ID: 35963316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells.
    Uslu D; Abas BI; Demirbolat GM; Cevik O
    Mol Divers; 2024 Apr; 28(2):449-460. PubMed ID: 36576666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
    Buocikova V; Longhin EM; Pilalis E; Mastrokalou C; Miklikova S; Cihova M; Poturnayova A; Mackova K; Babelova A; Trnkova L; El Yamani N; Zheng C; Rios-Mondragon I; Labudova M; Csaderova L; Kuracinova KM; Makovicky P; Kucerova L; Matuskova M; Cimpan MR; Dusinska M; Babal P; Chatziioannou A; Gabelova A; Rundén-Pran E; Smolkova B
    Biomed Pharmacother; 2022 Mar; 147():112662. PubMed ID: 35091237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.
    Deng Z; Rong Y; Teng Y; Zhuang X; Samykutty A; Mu J; Zhang L; Cao P; Yan J; Miller D; Zhang HG
    Oncogene; 2017 Feb; 36(5):639-651. PubMed ID: 27345402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
    Mei Y; Liao X; Zhu L; Yang H
    J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-network poly(Nɛ-acryloyl L-lysine)/hyaluronic acid hydrogel as a mimic of the breast tumor microenvironment.
    Xu W; Qian J; Zhang Y; Suo A; Cui N; Wang J; Yao Y; Wang H
    Acta Biomater; 2016 Mar; 33():131-41. PubMed ID: 26805429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells.
    Pullan J; Dailey K; Bhallamudi S; Feng L; Alhalhooly L; Froberg J; Osborn J; Sarkar K; Molden T; Sathish V; Choi Y; Brooks A; Mallik S
    ACS Appl Bio Mater; 2022 May; 5(5):2163-2175. PubMed ID: 35417133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Injectable Chitosan-based Co-cross-linking Hydrogel for Local Delivery of
    Huang FJ; Hung CC; Chang CW; Chao JH; Hsieh BT
    Anticancer Res; 2018 Aug; 38(8):4651-4659. PubMed ID: 30061232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity.
    Alimoradi H; Greish K; Barzegar-Fallah A; Alshaibani L; Pittalà V
    Int J Nanomedicine; 2018; 13():7771-7787. PubMed ID: 30538458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance.
    Yao S; Yin Y; Jin G; Li D; Li M; Hu Y; Feng Y; Liu Y; Bian Z; Wang X; Mao Y; Zhang J; Wu Z; Huang Z
    Cancer Med; 2020 Aug; 9(16):5989-5998. PubMed ID: 32618144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile.
    Nunes AS; Costa EC; Barros AS; de Melo-Diogo D; Correia IJ
    Biotechnol J; 2019 Apr; 14(4):e1800268. PubMed ID: 30242980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway.
    Wang N; Li X; Zhong Z; Qiu Y; Liu S; Wu H; Tang X; Chen C; Fu Y; Chen Q; Guo T; Li J; Zhang S; Zern MA; Ma K; Wang B; Ou Y; Gu W; Cao J; Chen H; Duan Y
    J Nanobiotechnology; 2021 Dec; 19(1):437. PubMed ID: 34930304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.